Literature DB >> 10402197

lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS.

J M Miwa1, I Ibanez-Tallon, G W Crabtree, R Sánchez, A Sali, L W Role, N Heintz.   

Abstract

Elapid snake venom neurotoxins exert their effects through high-affinity interactions with specific neurotransmitter receptors. A novel murine gene, lynx1, is highly expressed in the brain and contains the cysteine-rich motif characteristic of this class of neurotoxins. Primary sequence and gene structure analyses reveal an evolutionary relationship between lynx1 and the Ly-6/neurotoxin gene family. lynx1 is expressed in large projection neurons in the hippocampus, cortex, and cerebellum. In cerebellar neurons, lynx1 protein is localized to a specific subdomain including the soma and proximal dendrites. lynx1 binding to brain sections correlates with the distribution of nAChRs, and application of lynx1 to Xenopus oocytes expressing nAChRs results in an increase in acetylcholine-evoked macroscopic currents. These results identify lynx1 as a novel protein modulator for nAChRs in vitro, which could have important implications in the regulation of cholinergic function in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10402197     DOI: 10.1016/s0896-6273(00)80757-6

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  119 in total

1.  Lynx1, a cholinergic brake, limits plasticity in adult visual cortex.

Authors:  Hirofumi Morishita; Julie M Miwa; Nathaniel Heintz; Takao K Hensch
Journal:  Science       Date:  2010-11-11       Impact factor: 47.728

2.  The role of nicotinic acetylcholine receptors in the medial prefrontal cortex and hippocampus in trace fear conditioning.

Authors:  J D Raybuck; T J Gould
Journal:  Neurobiol Learn Mem       Date:  2010-08-19       Impact factor: 2.877

Review 3.  Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects.

Authors:  Henry A Lester; Julie M Miwa; Rahul Srinivasan
Journal:  Biol Psychiatry       Date:  2012-07-06       Impact factor: 13.382

4.  From genome to "venome": molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins.

Authors:  Bryan G Fry
Journal:  Genome Res       Date:  2005-03       Impact factor: 9.043

5.  Regulation of Kv1 channel trafficking by the mamba snake neurotoxin dendrotoxin K.

Authors:  Helene Vacher; Durga P Mohapatra; Hiroaki Misonou; James S Trimmer
Journal:  FASEB J       Date:  2006-12-21       Impact factor: 5.191

Review 6.  Anticoagulant proteins from snake venoms: structure, function and mechanism.

Authors:  R Manjunatha Kini
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

Review 7.  Inside-out neuropharmacology of nicotinic drugs.

Authors:  Brandon J Henderson; Henry A Lester
Journal:  Neuropharmacology       Date:  2015-02-04       Impact factor: 5.250

8.  Water-soluble LYNX1 residues important for interaction with muscle-type and/or neuronal nicotinic receptors.

Authors:  Ekaterina N Lyukmanova; Mikhail A Shulepko; Svetlana L Buldakova; Igor E Kasheverov; Zakhar O Shenkarev; Roman V Reshetnikov; Sergey Y Filkin; Denis S Kudryavtsev; Lucy O Ojomoko; Elena V Kryukova; Dmitry A Dolgikh; Mikhail P Kirpichnikov; Piotr D Bregestovski; Victor I Tsetlin
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

Review 9.  Critical periods in amblyopia.

Authors:  Takao K Hensch; Elizabeth M Quinlan
Journal:  Vis Neurosci       Date:  2018-01       Impact factor: 3.241

10.  Potassium channel modulation by a toxin domain in matrix metalloprotease 23.

Authors:  Srikant Rangaraju; Keith K Khoo; Zhi-Ping Feng; George Crossley; Daniel Nugent; Ilya Khaytin; Victor Chi; Cory Pham; Peter Calabresi; Michael W Pennington; Raymond S Norton; K George Chandy
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.